These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8520799)

  • 1. [Experimental models of toxoplasmosis. Pharmacological applications].
    Derouin F; Lacroix C; Sumyuen MH; Romand S; Garin YJ
    Parasite; 1995 Sep; 2(3):243-56. PubMed ID: 8520799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogeny and immunological control of toxoplasmosis.
    Derouin F
    Braz J Med Biol Res; 1992; 25(12):1163-9. PubMed ID: 1341911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
    Piergili Fioretti D
    Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with Toxoplasma gondii RH and Prugniaud strains in mice, rats and nude rats: kinetics of infection in blood and tissues related to pathology in acute and chronic infection.
    Zenner L; Foulet A; Caudrelier Y; Darcy F; Gosselin B; Capron A; Cesbron-Delauw MF
    Pathol Res Pract; 1999; 195(7):475-85. PubMed ID: 10448664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
    Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP
    Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii.
    Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF
    Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of Toxoplasma gondii infection in the nude rat. An experimental model of toxoplasmosis in the immunocompromised host?
    Foulet A; Zenner L; Darcy F; Cesbron-Delauw MF; Capron A; Gosselin B
    Pathol Res Pract; 1994 Sep; 190(8):775-81. PubMed ID: 7831153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice.
    Araujo FG
    J Immunol; 1992 Nov; 149(9):3003-7. PubMed ID: 1357033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigens of Toxoplasma gondii with a diagnostic and potential immunoprophylactic value: new strategies of identification].
    Darcy F; Torpier G; Cesbron-Delauw MF; Decoster A; Ridel PR; Duquesne V; Charif H; Godard I; Pierce RJ; Auriault C
    Ann Biol Clin (Paris); 1989; 47(7):451-7. PubMed ID: 2479305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Congenital toxoplasmosis].
    Hrnjaković-Cvjetković I; Jerant-Patić V; Cvjetković D; Mrdja E; Milosević V
    Med Pregl; 1998; 51(3-4):140-5. PubMed ID: 9611957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1 levels and intraocular tissue alterations in mice infected with a virulent type I RH Toxoplasma gondii strain.
    Iqbal J; Al-Awadhi MA; Raghupathy RG
    Exp Parasitol; 2016 Mar; 162():57-63. PubMed ID: 26773166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii: induction of toxoplasmic encephalitis in mice with chronic infection by inoculation of a murine leukemia virus inducing immunodeficiency.
    Watanabe H; Suzuki Y; Makino M; Fujiwara M
    Exp Parasitol; 1993 Feb; 76(1):39-45. PubMed ID: 8385626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine.
    Kim SK; Karasov A; Boothroyd JC
    Infect Immun; 2007 Apr; 75(4):1626-34. PubMed ID: 17261600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii: determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts.
    Chew WK; Wah MJ; Ambu S; Segarra I
    Exp Parasitol; 2012 Jan; 130(1):22-5. PubMed ID: 22027550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.
    Khan IA; Hakak R; Eberle K; Sayles P; Weiss LM; Urban JF
    Infect Immun; 2008 Mar; 76(3):1305-13. PubMed ID: 18195022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():87-92. PubMed ID: 3182450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.